Today’s active skin care ingredients provide a host of benefits to the skin – By Tom Branna , Editorial Director – Published December 2, 2015
Claims People Play
“In 2012, FDA issued nine Warning Letters to cosmetics companies for objectionable skin care claims, particularly anti-aging claims,” recalled Georgia Ravitz, a partner with Arent Fox LLP.
According to Ravitz, the increase in WLs in 2015 can be attributed generally to several factors:
- FDA’s increasing enforcement capability over the past 5-6 years. FDA has been slowly increasing its enforcement staff at CFSAN as well as conducting more online research to review product claims and promotions online.
- Some companies continue to market their products with aggressive enforcement claims, which is drawing FDA’s attention to product claims it views as objectionable.
- FDA has been unable to get Congress to pass cosmetics reform legislation that would increase FDA regulation of the industry.
- “Thus, FDA is using more active enforcement to try to keep industry in regulatory check,” she said.